GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Research & Development

Kineta (STU:J75) Research & Development : €8.23 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Kineta's Research & Development for the three months ended in Mar. 2024 was €2.51 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €8.23 Mil.

Kineta Research & Development Historical Data

The historical data trend for Kineta's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Research & Development Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
7.58 13.77 32.84 8.27

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 2.50 1.79 1.43 2.51

Kineta Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kineta  (STU:J75) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kineta Research & Development Related Terms

Thank you for viewing the detailed overview of Kineta's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Kineta (STU:J75) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Research & Development
Comparable Companies
GDTC OKYO MTNB SPRB YS DYAI DTIL COYA AGLE IMUX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
KA:USA
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Website
https://www.kinetabio.com
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines